Inflammation is a common soil for type 2 diabetes, heart attack and stroke. Vaccination (immunotherapy) eliminates pathogenic agents by eliciting a specific immune response. This Christian Doppler-Laboratory specifically develops immunotherapies to target crucial inflammatory molecules in order to prevent and treat type 2 diabetes and heart attacks.
- Lukas Leitner was awarded the abstract prize 2014 by the Austrian Society of Diabetes
- Lukas Leitner was awarded the prize of the Austrian Society of Obesity
- The osteopontin receptor CD44 emerges as a target for immunotherapy of obesity-induced type 2 diabetes
- Bianca Itariu is honored with the Research Prize from the Erste Bank